Appetite suppressants and pulmonary hypertension

Thorax

Volumn 52, Issue SUPPL. 3, 1997, Pages

  Voelkel, N F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOREX; AMPHETAMINE; ANOREXIGENIC AGENT; DEXFENFLURAMINE; FENFLURAMINE; FLUOXETINE; PHENTERMINE; SEROTONIN; SERTRALINE;

ARTICLE; BELGIUM; CONTROLLED STUDY; COUGHING; DYSPNEA; FAMILY HISTORY; FATIGUE; FRANCE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NETHERLANDS; OBESITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK BENEFIT ANALYSIS; RISK FACTOR; SEROTONIN RELEASE; UNITED KINGDOM; WEIGHT REDUCTION;

EID: 0030876401     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.2008.s63     Document Type: Article

References (35)

1. Kay JM. The pathology of primary pulmonary hypertension. Semin Respir Med 1985;7:141-6.
2. Phipps B, Wong B, Chang J, Dunn M. Unexplained severe pulmonary hypertension in the older age group. Chest 1983;84:399-402.
3. D'Alonzo GE., Barst RJ, Ayers SM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Ann Intern Med 1991;115:343-9.
4. Lebrec D, Capron J-P, Dhumeaux D, Benhamou J-P. Pulmonary hypertension complicating portal hypertension. Am Rev Respir Dis 1979; 120:819-56.
5. McDonnell PJ, Toye PA, Hutchins G. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir-Dis 1983;123:437-41.
6. Weiss JR. Pietra GG, Scharf SM. Primary pulmonary hypertension and the human immunodeficiency virus. Arch Intern Med 1995;155: 2350-4.
7. Brenot F, Herve P, Petipretz P, Parent F, Duroax P, Simonneau G. Primary pulmonary hypertension and fenluuramine use. Br Heart J 1993;70:517-41.
8. Weissman NJ, Fuster V. Diagnosis of pulmonary artery hypertension. Heart Dis Stroke 1992;1:196-201.
9. Rounds S, Hill NS. Pulmonary hypertensive diseases. Chest 1984;86: 397-405.
10. Ahenhaim L, Moride L, Brenot F, Rich S, Benichou J, Kurz X, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996;335:609-16.
11. Reeves JT, Voelkel NF. Primary pulmonary hypertension. In: Moser K, ed. Lung biology in health and disease. Vol 14. New York: Marcel Dekker, 1979: 573-628.
12. Gurtner HP, Gertsch M, Salzmann C, Scherrer M, Stucki P, Wyss F. Häufen sich die primär vasculären Formen des chronischen Cor pulmonale? Schweiz Med Wochenschr1968;98:1579-1695.
13. Voss H, Harms H. Epidemilogy and clinical aspects of primary vascular pulmonary hypertension. A report on 42 cases. Z Kreislacfforsch 1970; 59:887-91.
14. Gahl VK, Fabel H, Greiser E, Harmjanz D, Ostertag H, St Stender H. Primary vascular pulmonary hypertension. A report on 21 cases. Z. Kreislanfforsch 1970;59:868-83.
15. Kaindl VF. Primare pulmonale hypertension. Wien Z Inn Med 1969;50: 451-3.
16. Schwingshackl H, Amor H, Dienstl F. Primäre pulmonale hypertonic bei sieben jüngeren Frauen. Dtsch Med Wochenchr 1969;94:639-45.
17. Gahl VK, Fabel H, Greiser E, Harmjanz D, Ostertag H. St Stender H. Primäre vaskuläre pulmonale Hypertonie. Z. Kreislanfforsch 1970;59: 868-83.
18. Gurtner HP. Chronische pulmonale Hypertonie vaskulären Ursprangs, plexogene pulmonale arteriopathic and der appetizügler aminorex: nachlese zu einer epidemic. Schweiz Med Wochenschr 1985;115:782-9.
19. Kay JM, Smith P, Heath D. Aminorex and the pulmonary circulation. Thorax 1971;26:262-70.
20. Gahl K, Greiser E. Erfahrungern einer klinisch-epidemiologischen Studie zum problem der primär vaskulären pulmonalen Hypertonie. Schweiz Med Wochenschr 1970;100:2154-7.
21. Greiser E. Epidemiologische Untersuchungen zum Zusammenhang zwischen Appetitzüglereinnahme und primär vasculärer pulmonaler Hypertonie. Internist 1973;14:437-42.
22. Kraupp VO. Tierexperimentelle Untersuchungen zur Ätiologie der primären pulmonalen Hypertension. Wein Z Inn Med 1969;50:493-6.
23. Byrne-Quinn E, Grover RF. Aminorex (Menocil) and amphetamine: acute and chronic effects on pulmonary and systemic haemodynamics in the calf. Thorax 1972;27:127-31.
24. Lullmann, Parwaresch MR, Sattler M, Seiler KU, Siegfriedt A. The effects of anorectic agents on the pulmonary pressure and morphology of rat lungs after chronic administration. Arznemittel-Forschung 1972; 22:2096-9.
25. Voelkel NF, Clarke WR, Higenbottam T, Obesity, dexfenfluramine, and pulmonary hypertension: a lesson not learned? Am J Respir Crit Care Med 1997;155:786-8.
26. Herve P, Drouet L, Dosquet C, Launay J-M, Rain B, Simonneau G, et al. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med 1990;89:117-20.
27. Herve P, Launay J-M, Scrobohaci M-L, Brenot F, Simonneau G, Petitpretz P, et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995;99:249-54.
28. McGoon MD, Vanhoutte PM. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine. J Clin Invest 1984;74:828-33.
29. Lee S-L, Wang WW, Lanzillo JJ, Fanburg BL. Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am J Physiol 266(Lung Cell Mol Physiol 10): 1994:L46-52.
30. Lee S-L, Wang WW, Fanburg BL. Nitroprusside inhibits serotonin-induced mitogenesis and tyrosine phosphorylation of smooth muscle cells. Am J Physiol 270 (Lung Cell Mol Physiol 14): 1996:L362-7.
31. Pitt BR, Weng W, Steve AR, Blakely RD, Reynolds I, Davics P. Serotonin increased DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am J Physiol 266(Lung Cell Mol Physiol 10):1994:L178-86.
32. Abenhaim L, Rich S, Benichou J, Begaud B. Letter to the editor. N Engl J Med 1997;336:512-3.
33. Naeije R, Wauthy P, Maggiorini M, Leeman M, Delcroix M. Effects of dexfenfiuramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs. Am J Respir Crit Care Med 1995; 151:692-7.
34. National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996;276:1907-15.
35. Voelkel N. Drug-induced pulmonary hypenension: must history repeat itself? Pulm Pharmcol 1996;9:67-8.